User Fees, Drug Shortages, Off-Label Issues Among PLIR Board's Top Concerns for 2012
BNA Pharmaceutical Law & Industry Report
1/13/2012
In this article, "User Fees, Drug Shortages, Off-Label Issues Among PLIR Board's Top Concerns for 2012," published in BNA Pharmaceutical Law & Industry Report on January 13, 2012, Mintz Levin attorney Linda Bentley is quoted discussing these pressing issues for Capitol Hill and the Food and Drug Administration in the coming year.
Click here to read the article in full.
